MXPA02008072A - Composicion farmaceutica. - Google Patents

Composicion farmaceutica.

Info

Publication number
MXPA02008072A
MXPA02008072A MXPA02008072A MXPA02008072A MXPA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A MX PA02008072 A MXPA02008072 A MX PA02008072A
Authority
MX
Mexico
Prior art keywords
membrane
nail
solvent
solution
permeation enhancer
Prior art date
Application number
MXPA02008072A
Other languages
English (en)
Inventor
Robert J Gyurik
Original Assignee
Bentley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc filed Critical Bentley Pharmaceuticals Inc
Publication of MXPA02008072A publication Critical patent/MXPA02008072A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe una composicion que comprende un compuesto farmaceutico, un aumentador de la permeacion de membrana, y un agente polimerico que forma una pelicula, que incluye, por ejemplo, una laca liquida de unas con base en hidrocarburo que comprende una solucion de un agente anti-fungal en una cantidad farmaceuticamente efectiva, un aumentador de la permeacion compatible con la membrana en una cantidad efectiva para aumentar la penetracion a traves de la membrana o de la una del agente anti-fungal, un agente polimerico que forma una pelicula en una cantidad efectiva para formar una pelicula polimerica adherente en la membrana o la una, y un solvente para formar la solucion; y un metodo para formar en la membrana o la una del cuerpo una pelicula adherente que contiene el compuesto farmaceutico y el aumentador de la permeacion de una solucion de los componentes en los cuales se usa una mezcla de solventes, que incluye un solvente que es altamente volatil y un solvente con una volatilidad menor.
MXPA02008072A 2000-02-16 2001-02-16 Composicion farmaceutica. MXPA02008072A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
MXPA02008072A true MXPA02008072A (es) 2004-04-05

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02008072A MXPA02008072A (es) 2000-02-16 2001-02-16 Composicion farmaceutica.

Country Status (17)

Country Link
EP (1) EP1257248B1 (es)
JP (1) JP2005503318A (es)
KR (2) KR20080049148A (es)
CN (1) CN1422142A (es)
AT (1) ATE526917T1 (es)
AU (2) AU2001243189B2 (es)
BR (1) BR0108438A (es)
CA (1) CA2400178A1 (es)
HU (1) HUP0204555A3 (es)
MA (1) MA26883A1 (es)
MX (1) MXPA02008072A (es)
NO (1) NO20023866L (es)
NZ (1) NZ520749A (es)
PL (1) PL357111A1 (es)
TW (1) TWI232756B (es)
WO (1) WO2001060325A1 (es)
ZA (1) ZA200206553B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
DK1545619T3 (da) 2002-09-05 2008-05-26 Galderma Sa Oplösning til ungual påföring
KR101093990B1 (ko) * 2003-03-21 2011-12-16 넥스메드 홀딩스 인코포레이티드 항진균성 네일 코트 및 사용 방법
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
EP1947938A4 (en) * 2005-11-02 2009-07-01 Cpex Pharmaceuticals Inc MACROCYCLIC FORMULATIONS FOR TRANSMEMBRANE DRUG DELIVERY
AU2006326388B2 (en) * 2005-12-14 2013-01-24 Nuvo Research Inc. Compositions and methods for treating dermatological conditions
JP5290582B2 (ja) * 2005-12-28 2013-09-18 帝國製薬株式会社 爪用医薬組成物
US20100028447A1 (en) 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
JP5654497B2 (ja) * 2009-02-13 2015-01-14 トピカ ファーマシューティカルズ,インコーポレイテッド 抗真菌製剤
EP2408299B1 (en) * 2009-03-20 2013-10-23 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
KR101580077B1 (ko) 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
EP0503312B1 (fr) * 1991-03-13 1997-01-08 Firmenich Sa Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide
EP0805673A1 (en) * 1994-10-20 1997-11-12 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
PT983037E (pt) * 1998-02-09 2003-09-30 Macrochem Corp Verniz para unhas antifungico
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
KR20030016227A (ko) 2003-02-26
CN1422142A (zh) 2003-06-04
ZA200206553B (en) 2003-11-17
PL357111A1 (en) 2004-07-12
NZ520749A (en) 2004-06-25
CA2400178A1 (en) 2001-08-23
KR20080049148A (ko) 2008-06-03
JP2005503318A (ja) 2005-02-03
NO20023866L (no) 2002-10-01
NO20023866D0 (no) 2002-08-15
EP1257248B1 (en) 2011-10-05
ATE526917T1 (de) 2011-10-15
EP1257248A1 (en) 2002-11-20
HUP0204555A2 (en) 2003-05-28
MA26883A1 (fr) 2004-12-20
AU4318901A (en) 2001-08-27
HUP0204555A3 (en) 2004-06-28
WO2001060325A1 (en) 2001-08-23
EP1257248A4 (en) 2007-10-03
AU2001243189B2 (en) 2005-06-09
TWI232756B (en) 2005-05-21
BR0108438A (pt) 2003-04-01

Similar Documents

Publication Publication Date Title
MXPA02008072A (es) Composicion farmaceutica.
UA27143C2 (uk) Рідка фармацевтичhа композиція в формі аерозолю
NZ330136A (en) Stable liquid paracetamol compositions comprising polyhydric or water soluble alcanol and buffering agent, and further containing a free radical antagonist or scavenger
BG103221A (en) Pharmaceutical composition in aerosol form
WO1995001167A3 (en) Incorporating poly-n-vinyl amide in a transdermal system
MY101536A (en) Anti-inflammatory and analgesic tape for external use
JP2005503318A5 (es)
WO2005099676A3 (en) Transdermal delivery system for use with basic permeation enhancers
TNSN04080A1 (en) Method and composition for improving fuel combustion
GEP20033129B (en) Pressurised Metered Dose Inhalers and Aerosol Formulation
NZ504653A (en) Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones
MY130857A (en) Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
BR9505201A (pt) Agente de extração de tinta alcalino contendo álcool benzilico como em sistema solvente composição para extração de tinta e processos de preparação de um removedor de alcalino de revestimento ou emuls o água-em-óleo de agente de extração de tinta e de extrção de tinta de poliuterano sobre uma camada de primeira mão de epóxi sobre metal
NO954957L (no) Synergistisk stabiliserte flytende enzymatiske blandinger
WO2001055092A3 (de) 5-aminolävulinsäure-formulierung in nichtwässrigen lösungsmitteln
EP1125497A3 (de) Mittel zur viruziden Händedesinfektion
MXPA04000028A (es) Formulacion farmaceutica para la administracion intramuscular de fulvestrant.
KR880002524A (ko) 니코란딜 외용제
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
EP1245655A3 (en) Thermosetting coating composition and coating film forming method using the same
WO2001049273A3 (de) Pharmazeutische zusammensetzung zur transdermalen verabreichung von hormonen mit einem permeationsverbessernden zusatzstoff
AR002981A1 (es) Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
DK0773884T3 (da) Opløsningssystem til en flydende opløsning, der indeholder en aktiv ingrediens
CA2548739A1 (en) Uv-stable, liquid or semisolid transdermal administration form comprising a photosensitive active ingredient

Legal Events

Date Code Title Description
FA Abandonment or withdrawal